No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CLVT Clarivate
- 7.140
- +0.140+2.00%
Trading Apr 26 15:05 ET
4.77BMarket Cap-4857P/E (TTM)
7.240High7.000Low1.58MVolume7.030Open7.000Pre Close11.27MTurnover0.39%Turnover RatioLossP/E (Static)668.14MShares10.03052wk High1.04P/B2.89BFloat Cap6.07052wk Low--Dividend TTM405.17MShs Float34.790Historical High--Div YieldTTM3.43%Amplitude3.631Historical Low7.143Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
RTX Recognized for Industry Leading Innovation in Patented Technology
Company sees top rankings from multiple organizations globally ARLINGTON, Va., April 25, 2024 /PRNewswire/ -- RTX (NYSE: RTX) received recognition from three separate organizations for innovation in
Express News | NYSE Order Imbalance 73598.0 Shares on Buy Side
Are Investors Undervaluing Clarivate Plc (NYSE:CLVT) By 38%?
Key Insights Clarivate's estimated fair value is US$11.48 based on 2 Stage Free Cash Flow to Equity Clarivate is estimated to be 38% undervalued based on current share price of US$7.14 Analyst pr
Express News | Clarivate Joins United Nations Sustainable Development Goals (UN SDGs) Publishers Compact
Express News | NYSE Order Imbalance 160272.0 Shares on Buy Side
Express News | Clarivate Acquires Global QMS Expanding Life Sciences & Healthcare Segment Into New Markets
Comments
1
Clarivate's low ROE and significant net income drop over the last five years could negatively affect share price momentum. Despite retaining most profits, the lack of earnings growth points to other limiting factors. However, predicted slight earnings growth improvement may comfort shareholders.
Clarivate's strong earnings seem exaggerated due to unusual items and tax benefits, raising skepticism about the firm's true profitability. Future profitability could drop if these benefits aren't repeated, causing concerns for investors.
ColumnsToday's Pre-Market Stock Movers and Top Ratings: ADBE, RH, GS, GILD and More
Pre-Market Stock Movers
Gapping up
$Adobe(ADBE.US$ stock rose 1.6% after Mizuho Securities upgraded the computer software company to ‘buy’ from ‘neutral’, saying it is well-positioned to capitalize on digital transformation with its highly comprehensive end-to-end offering.
$DocuSign(DOCU.US$ stock rose 1% after the e-signature company beat expectations in its second quarter, with revenue up 10.5% year-on-year, and thu...
Gapping up
$Adobe(ADBE.US$ stock rose 1.6% after Mizuho Securities upgraded the computer software company to ‘buy’ from ‘neutral’, saying it is well-positioned to capitalize on digital transformation with its highly comprehensive end-to-end offering.
$DocuSign(DOCU.US$ stock rose 1% after the e-signature company beat expectations in its second quarter, with revenue up 10.5% year-on-year, and thu...
21
1
ColumnsUS Top Gap Ups and Downs on 8/3: REGN, PYPL, QCOM, MCK and More
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Clorox(CLX.US$ - up 4.6%
2. $Cognizant(CTSH.US$ - up 4.1%
3. $Informatica(INFA.US$ - up 2.8%
4. $Kanzhun(BZ.US$ - up 2.7%
5. $Sunrun(RUN.US$ - up 2.6%
6. $Regeneron Pharmaceuticals(REGN.US$ - up 1.9%
7. $McKesson(MCK.US$ - up 1.9%
8. $Curtiss-Wright(CW.US$ - up 1.7%
9. $MercadoLibre(MELI.US$ - up 1.5...
Gap Ups
1. $Clorox(CLX.US$ - up 4.6%
2. $Cognizant(CTSH.US$ - up 4.1%
3. $Informatica(INFA.US$ - up 2.8%
4. $Kanzhun(BZ.US$ - up 2.7%
5. $Sunrun(RUN.US$ - up 2.6%
6. $Regeneron Pharmaceuticals(REGN.US$ - up 1.9%
7. $McKesson(MCK.US$ - up 1.9%
8. $Curtiss-Wright(CW.US$ - up 1.7%
9. $MercadoLibre(MELI.US$ - up 1.5...
+16
21
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg